Agragene
San Diego, US · Founded 2017 · Delaware corporation · 2 known investors
Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides. It serves agricultural growers of berries and cherries in the US and Canada, working alongside integrated pest management programs.
AgTechBiotechClimate Tech
Founders & leadership
BW

Bryan WitherbeeinPresident and CEO
TE
Tracy EllisNamed on SEC filing
CS
Clyde ShoresNamed on SEC filing
RS
Robert SchmidtNamed on SEC filing
GA
Gordon AltonNamed on SEC filing
DW
David WebbNamed on SEC filing
Board
CC

Investors · 2
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 2 rounds · 2020–2021
▶$145KraisedFeb 2021 · 1 investors · OtherRule 506(b)
▶$145KraisedFeb 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tracy EllisExecutive Officer
- Robert SchmidtDirector
- David WebbDirector
- Carl CasaleDirector
- Gordon AltonExecutive Officer, Director
- Clyde ShoresExecutive Officer, Director
- Offering amount
- $145K
- Amount sold
- $145K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.1MraisedAug 2020 · 17 investors · OtherRule 506(b)
▶$2.1MraisedAug 2020 · 17 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tracy EllisExecutive Officer
- Carl CasaleDirector
- Clyde ShoresExecutive Officer, Director
- Robert SchmidtDirector
- Gordon AltonExecutive Officer, Director
- David WebbDirector
- Offering amount
- $7.5M
- Amount sold
- $2.1M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapOrigene17 shared keywordsOriGene supplies research reagents including primary antibodies for flow cytometry, transfection kits (EZ-LNP and ProteanFect), RNAi gene silencing tools, and control solutions for life science laboratories. Its products serve researchers in molecular and cell biology.
Neurogene14 shared keywordsNeurogene develops gene therapies for rare neurological diseases, particularly Rett syndrome, using proprietary transgene regulation technology. The company serves patients and families affected by devastating neurological disorders.
Seegene Venture Capital12 shared keywordsSeegene is a molecular diagnostics company; this page is its investor relations section listing quarterly earnings release IR books available for download.
Companies competing with Agragene for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Agragene do?
- Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides. It serves agricultural growers of berries and cherries in the US and Canada, working alongside integrated pest management programs.
- Who are Agragene's investors?
- Agragene's investors include Missouri Technology Corporation, Ospraie Ag Science.
- How much funding has Agragene raised?
- Agragene has disclosed $2.2M raised across 2 rounds.
- Where is Agragene headquartered?
- Agragene is headquartered in San Diego, US.
